Lv615
1866 积分 2024-10-23 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2天前
已完结
Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management
2天前
已完结
Metabolic dysfunction-associated steatotic liver disease and adverse pregnancy outcomes: a nationwide cohort study
2天前
已完结
Global epidemiology of cirrhosis — aetiology, trends and predictions
3天前
已完结
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
3天前
已完结
Hepatic steatosis index for prediction of metabolic dysfunction‐associated steatotic liver disease ( MASLD ) among young Indian women with gestational diabetes and normoglycaemia during index pregnancy
5天前
已完结
Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year‐community study
6天前
已完结
Epidemiologic Trends in Acute, Chronic, and Pregnancy-Specific Liver Diseases in Pregnancy
6天前
已完结
Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B
6天前
已完结
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
6天前
已完结
皖公网安备34019202002308
